SEFLOX INFUSION Cirprofloxacin Intravenous infusion 200 mg/100ml)
SEFLOX INFUSION (Cirprofloxacin Intravenous infusion 200 mg/100ml)
Antibacterial Agent
Inhibits both type II topoisomerase (DNA-gyrase) & topoisomerase IV
CIPROFLOXACIN SUSCEPTIBLE SPECIIS : Aerobic Gram negative micro organisms:
- M.Catarrhalis, Neisseria meningitidis, Pasteurella SPP, Salmonella SPP, Shigella SPP, Vibrio SPP, Yersinia Pestis, Aeromonas SPP, Brucella SPP, Citrobacter Koseri Francisella tularensis, H.ducreyi, H.influenzae & Legionella SPP
Aerobic Gram positive micro Organisms
- Bacillus anthracis
Anaerobic micro Organisms
- Mobiluncus
Other micro Organisms
- Chlamydia trachomatis, Chlamydia pneumoniae, Mycoplasma hominis, Mycoplasma Pneumoniae
| Infection | Dose/Frequency | Duration |
| Urinary Tract Adults | 200 mg to 400 mg/ 8 12 hours | 7-14 days |
| Urinary Tract Children | 6mg/kg to 10 mg/kg 8 hours | 10-21 days |
| Lower Respiratory Tract | 400 mg / 8-12 hours | 7-14 days |
| Skin and skin structure | 400 mg / 8-12 hours | 7-14 days |
| Bone and Joint | 400 mg / 8-12 hours | 4 to 8 weeks |
| Complicated intra Abdominal | 400 mg / 12 hours | 7-14 days |
| Acute Sinusitis | 400 mg / 12 hours | 10 days |
| chronic Bacterial Prostatitis | 400 mg / 12 hours | 28 days |
| Nosocomial Pneumonia | 400 mg/ 8 hours | 10-14 days |
